Access Resources
4776 - 4800 of 7540 Results
Title
Year
- Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)2019RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
-
RESTRICTEDTitle: Defective homologous recombination DNA repair as therapeutic target in advanced chordomaJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-09633-9Best OA location URL: https://www.nature.com/articles/s41467-019-09633-9.pdfCitation Count: 61
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
- NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)2019RESTRICTEDTitle: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035Citation Count: 0
-
RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
-
RESTRICTEDTitle: Cognitive Performance in Parkinson’s Disease in the Brain Health RegistryJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 68Issue #: 3Start Page: 1029End Page: 1038Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-181009Best OA location URL: https://europepmc.org/articles/pmc6497062?pdf=renderCitation Count: 8
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age2019RESTRICTEDTitle: Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced ageJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-09613-zBest OA location URL: https://www.nature.com/articles/s41467-019-09613-z.pdfCitation Count: 142
- Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms2019RESTRICTEDTitle: Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanismsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 6Start Page: 866End Page: 875Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27659Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A2986168/viewCitation Count: 252
-
RESTRICTEDTitle: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s DiseaseJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 5Start Page: 2109End Page: 2120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982Best OA location URL: https://discovery.ucl.ac.uk/10072865/3/Zetterberg%20Bhattacharjee.pdfCitation Count: 49
- Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System2019RESTRICTEDTitle: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 11Issue #: 1Start Page: 301End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011Best OA location URL: https://doi.org/10.1016/j.dadm.2019.01.011Citation Count: 29
-
RESTRICTEDTitle: The sncRNA Zoo: a repository for circulating small noncoding RNAs in animalsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 47Issue #: 9Start Page: 4431End Page: 4441Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkz227Best OA location URL: https://academic.oup.com/nar/article-pdf/47/9/4431/28603181/gkz227.pdfCitation Count: 8
- A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging2019RESTRICTEDTitle: A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 69End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.12.050Best OA location URL: http://escholarship.mcgill.ca/downloads/f4752n84fCitation Count: 65
- Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs2019RESTRICTEDTitle: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 148Issue #:Start Page: 220End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015Citation Count: 13
- Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease2019RESTRICTEDTitle: Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 94End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.021Best OA location URL: https://europepmc.org/articles/pmc6041186?pdf=renderCitation Count: 16
- Distinct Missense Mutations of the Parkinson's Disease‐Related Ubiquitin Kinase PINK1 Alter Auto‐ or Substrate‐Phosphorylation2019RESTRICTEDTitle: Distinct Missense Mutations of the Parkinson's Disease‐Related Ubiquitin Kinase PINK1 Alter Auto‐ or Substrate‐PhosphorylationJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2019.33.1_supplement.lb329Citation Count: 0
-
RESTRICTEDTitle: Episodic recognition memory and the hippocampus in Parkinson's disease: A reviewJournal Name: CortexPublisher: Elsevier BVVol: 113Issue #:Start Page: 191End Page: 209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2018.11.021Best OA location URL: https://europepmc.org/articles/pmc6445686?pdf=renderCitation Count: 69
-
RESTRICTEDTitle: Genetic analysis of neurodegenerative diseases in a pathology cohortJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 214.e1End Page: 214.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007Best OA location URL: https://europepmc.org/articles/pmc6391207?pdf=renderCitation Count: 24
- High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra2019RESTRICTEDTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Best OA location URL: https://europepmc.org/articles/pmc6438360?pdf=renderCitation Count: 36
- Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion2019RESTRICTEDTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://europepmc.org/articles/pmc6443492?pdf=renderCitation Count: 9
- Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson's disease2019RESTRICTEDTitle: Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson's diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 5Issue #: 4Start Page: e01481End Page: e01481Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e01481Best OA location URL: http://www.cell.com/article/S2405844018372189/pdfCitation Count: 19
-
RESTRICTEDTitle: Multimodal MRI evaluation of parkinsonian limbic pathologiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 194End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004Best OA location URL: https://europepmc.org/articles/pmc6461740?pdf=renderCitation Count: 13
-
RESTRICTEDTitle: Neural correlates of distinct cognitive phenotypes in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 399Issue #:Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013Best OA location URL: https://europepmc.org/articles/pmc6436969?pdf=renderCitation Count: 8
-
RESTRICTEDTitle: Nucleic Acid–Based Therapeutics for Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 43
-
RESTRICTEDTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://www.repository.cam.ac.uk/bitstream/1810/287349/1/YNBDI_2018_257_Original_V0-2-4-72.pdfCitation Count: 32